Albemarle (ALB) Declines More Than Market: Some Information for Investors

Company Performance - Albemarle's stock closed at $58.10, reflecting a -0.7% change from the previous day, underperforming the S&P 500's daily loss of 0.23% [1] - Over the past month, Albemarle's shares have decreased by 22.51%, significantly trailing the Basic Materials sector's loss of 8.32% and the S&P 500's loss of 12.13% [1] Upcoming Earnings - The upcoming earnings report for Albemarle is scheduled for April 30, 2025, with an expected EPS of -$ 0.37, indicating a 242.31% decline from the same quarter last year [2] - Revenue is forecasted to be $1.2 billion, representing an 11.86% decrease compared to the same quarter of the previous year [2] Full Year Estimates - For the full year, analysts expect earnings of -$ 0.05 per share and revenue of $5.02 billion, which would reflect a +97.86% change in earnings and a -6.69% change in revenue from the previous year [3] - Recent changes to analyst estimates suggest evolving short-term business trends, with positive revisions indicating a favorable business outlook [3] Zacks Rank and Industry Performance - Albemarle currently holds a Zacks Rank of 3 (Hold), with a consensus EPS projection that has decreased by 14.29% in the past 30 days [5] - The Chemical - Diversified industry, which includes Albemarle, has a Zacks Industry Rank of 214, placing it in the bottom 14% of over 250 industries [6]